Literature DB >> 19167345

Gain-of-function mutation of Nav1.5 in atrial fibrillation enhances cellular excitability and lowers the threshold for action potential firing.

Qiuju Li1, Hai Huang, Gele Liu, Khanh Lam, Julie Rutberg, Martin S Green, David H Birnie, Robert Lemery, Mohamed Chahine, Michael H Gollob.   

Abstract

Genetic mutations of the cardiac sodium channel (SCN5A) specific only to the phenotype of atrial fibrillation have recently been described. However, data on the biophysical properties of SCN5A variants associated with atrial fibrillation are scarce. In a mother and son with lone atrial fibrillation, we identified a novel SCN5A coding variant, K1493R, which altered a highly conserved residue in the DIII-IV linker and was located six amino acids downstream from the fast inactivation motif of sodium channels. Biophysical studies of K1493R in tsA201 cells demonstrated a significant positive shift in voltage-dependence of inactivation and a large ramp current near resting membrane potential, indicating a gain-of-function. Enhanced cellular excitability was observed in transfected HL-1 atrial cardiomyocytes, including spontaneous action potential depolarizations and a lower threshold for action potential firing. These novel biophysical observations provide molecular evidence linking cellular "hyperexcitability" as a mechanism inducing vulnerability to this common arrhythmia.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19167345     DOI: 10.1016/j.bbrc.2009.01.052

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  37 in total

1.  Reversing nerve cell pathology by optimizing modulatory action on target ion channels.

Authors:  Jenny Tigerholm; Erik Fransén
Journal:  Biophys J       Date:  2011-10-19       Impact factor: 4.033

Review 2.  Emerging directions in the genetics of atrial fibrillation.

Authors:  Nathan R Tucker; Patrick T Ellinor
Journal:  Circ Res       Date:  2014-04-25       Impact factor: 17.367

Review 3.  The Role of Pharmacogenetics in Atrial Fibrillation Therapeutics: Is Personalized Therapy in Sight?

Authors:  Dawood Darbar
Journal:  J Cardiovasc Pharmacol       Date:  2016-01       Impact factor: 3.105

Review 4.  Genetics of atrial fibrillation: from families to genomes.

Authors:  Ingrid E Christophersen; Patrick T Ellinor
Journal:  J Hum Genet       Date:  2015-05-21       Impact factor: 3.172

5.  A distinct de novo expression of Nav1.5 sodium channels in human atrial fibroblasts differentiated into myofibroblasts.

Authors:  Aurélien Chatelier; Aurélie Mercier; Boris Tremblier; Olivier Thériault; Majed Moubarak; Najate Benamer; Pierre Corbi; Patrick Bois; Mohamed Chahine; Jean François Faivre
Journal:  J Physiol       Date:  2012-07-16       Impact factor: 5.182

6.  Atrial Fibrillation and SCN5A Variants.

Authors:  Eleonora Savio-Galimberti; Dawood Darbar
Journal:  Card Electrophysiol Clin       Date:  2014-12-01

Review 7.  A contemporary review on the genetic basis of atrial fibrillation.

Authors:  Jason D Roberts; Michael H Gollob
Journal:  Methodist Debakey Cardiovasc J       Date:  2014 Jan-Mar

Review 8.  Genomics of Atrial Fibrillation.

Authors:  Alejandra Gutierrez; Mina K Chung
Journal:  Curr Cardiol Rep       Date:  2016-06       Impact factor: 2.931

Review 9.  Genetic mechanisms of atrial fibrillation: impact on response to treatment.

Authors:  Dawood Darbar; Dan M Roden
Journal:  Nat Rev Cardiol       Date:  2013-04-16       Impact factor: 32.419

Review 10.  Cardiac sodium channelopathies.

Authors:  Ahmad S Amin; Alaleh Asghari-Roodsari; Hanno L Tan
Journal:  Pflugers Arch       Date:  2009-11-29       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.